Brief: Better Therapeutics Receives FDA Authorization For Aspyrerx™ To Treat Adults With Type 2 Diabetes
10/07/2023 23:07
July 10 (Reuters) - Better Therapeutics Inc BTTX.O :
* BETTER THERAPEUTICS RECEIVES FDA AUTHORIZATION FOR
ASPYRERX™ TO
TREAT ADULTS WITH TYPE 2 DIABETES
* ASPYRERX IS EXPECTED TO LAUNCH COMMERCIALLY IN Q4 2023
Source text for Eikon: ID:nBw3hwK8Ra
Further company coverage: BTTX.O
Recent news on Better Therapeutics
See all newsU.S. STOCKS ON THE MOVE-WiSA Technologies, Rivian Automotive, Cigna Group
U.S. STOCKS ON THE MOVE-Morgan Stanley, Intra-Cellular Therapies, China SXT Pharmaceuticals
U.S. STOCKS ON THE MOVE-Snap One, Encore Wire, Centene
U.S. STOCKS ON THE MOVE-Cisco Systems, Inspired Entertainment, Spirit Airlines
U.S. STOCKS ON THE MOVE-G-III Apparel Group, Tesla, MicroStrategy